Anna M. Sureda

551 total citations · 1 hit paper
6 papers, 145 citations indexed

About

Anna M. Sureda is a scholar working on Oncology, Pathology and Forensic Medicine and Genetics. According to data from OpenAlex, Anna M. Sureda has authored 6 papers receiving a total of 145 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 4 papers in Pathology and Forensic Medicine and 3 papers in Genetics. Recurrent topics in Anna M. Sureda's work include Lymphoma Diagnosis and Treatment (4 papers), Chronic Lymphocytic Leukemia Research (3 papers) and Viral-associated cancers and disorders (2 papers). Anna M. Sureda is often cited by papers focused on Lymphoma Diagnosis and Treatment (4 papers), Chronic Lymphocytic Leukemia Research (3 papers) and Viral-associated cancers and disorders (2 papers). Anna M. Sureda collaborates with scholars based in Spain, United States and United Kingdom. Anna M. Sureda's co-authors include Jaap Jan Boelens, Bruce L. Levine, Michael P. Gustafson, Edwin M. Horwitz, Annalisa Ruggeri, David L. Porter, John E. Connolly, Fabio Ciceri, Frederick L. Locke and John A. Snowden and has published in prestigious journals such as Nature Medicine, Journal of Clinical Oncology and American Journal of Hematology.

In The Last Decade

Anna M. Sureda

4 papers receiving 142 citations

Hit Papers

Unanswered questions following reports of secondary malig... 2024 2026 2025 2024 40 80 120

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anna M. Sureda Spain 3 127 51 35 27 23 6 145
Valentín Ortiz‐Maldonado Spain 9 108 0.9× 39 0.8× 22 0.6× 41 1.5× 28 1.2× 22 158
Anna Christina Dragon Germany 5 126 1.0× 51 1.0× 47 1.3× 74 2.7× 41 1.8× 9 183
Faustine Lhomme France 9 117 0.9× 50 1.0× 27 0.8× 96 3.6× 24 1.0× 13 201
Alexis Cuffel France 6 105 0.8× 45 0.9× 20 0.6× 60 2.2× 34 1.5× 7 140
Diana Bouhassira United States 4 84 0.7× 30 0.6× 28 0.8× 30 1.1× 24 1.0× 7 125
Caroline Besley United Kingdom 6 109 0.9× 27 0.5× 20 0.6× 24 0.9× 17 0.7× 16 147
Sara Silbert United States 5 224 1.8× 78 1.5× 44 1.3× 69 2.6× 73 3.2× 17 257
Michelle J. Cox United States 8 129 1.0× 46 0.9× 43 1.2× 30 1.1× 38 1.7× 24 144
Jessica Hulitt United States 3 82 0.6× 59 1.2× 41 1.2× 79 2.9× 19 0.8× 4 187
Daniella Cook United States 7 167 1.3× 64 1.3× 40 1.1× 30 1.1× 60 2.6× 14 185

Countries citing papers authored by Anna M. Sureda

Since Specialization
Citations

This map shows the geographic impact of Anna M. Sureda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna M. Sureda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna M. Sureda more than expected).

Fields of papers citing papers by Anna M. Sureda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna M. Sureda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna M. Sureda. The network helps show where Anna M. Sureda may publish in the future.

Co-authorship network of co-authors of Anna M. Sureda

This figure shows the co-authorship network connecting the top 25 collaborators of Anna M. Sureda. A scholar is included among the top collaborators of Anna M. Sureda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna M. Sureda. Anna M. Sureda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

6 of 6 papers shown
1.
Mallo, Mar, Neus Ruiz‐Xivillé, Anna M. Sureda, et al.. (2025). Optical Genome Mapping ( OGM ): Validation and Clinical Utility in the Cytogenetic Diagnosis of Multiple Myeloma. American Journal of Hematology. 100(11). 2114–2117.
2.
Levine, Bruce L., Marcelo C. Pasquini, John E. Connolly, et al.. (2024). Unanswered questions following reports of secondary malignancies after CAR-T cell therapy. Nature Medicine. 30(2). 338–341. 132 indexed citations breakdown →
3.
Chen, Robert W., Stephen M. Ansell, Andrea Gallamini, et al.. (2018). Brentuximab vedotin with chemotherapy for stage III or IV Hodgkin lymphoma (HL): Impact of cycle 2 PET result on modified progression-free survival (mPFS).. Journal of Clinical Oncology. 36(15_suppl). 7539–7539. 6 indexed citations
4.
Straus, David J., Graham P. Collins, Jan Walewski, et al.. (2018). Improving outcomes with brentuximab vedotin (BV) plus chemotherapy in patients with newly diagnosed advanced stage Hodgkin lymphoma.. Journal of Clinical Oncology. 36(15_suppl). 7534–7534. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026